Health-related quality of life in patients with metastatic colorectal cancer, association with systemic inflammatory response and RAS and BRAF mutation status.

MLA

Thomsen, Maria, et al. “Health-Related Quality of Life in Patients with Metastatic Colorectal Cancer, Association with Systemic Inflammatory Response and RAS and BRAF Mutation Status.” European Journal of Cancer, vol. 81, Aug. 2017, pp. 26–35. EBSCOhost, https://doi.org/10.1016/j.ejca.2017.04.026.

APA

Thomsen, M., Guren, M. G., Skovlund, E., Glimelius, B., Hjermstad, M. J., Johansen, J. S., Kure, E., Sorbye, H., Pfeiffer, P., Christoffersen, T., Guren, T. K., & Tveit, K. M. (2017). Health-related quality of life in patients with metastatic colorectal cancer, association with systemic inflammatory response and RAS and BRAF mutation status. European Journal of Cancer, 81, 26–35. https://doi.org/10.1016/j.ejca.2017.04.026

Chicago

Thomsen, Maria, Marianne Grønlie Guren, Eva Skovlund, Bengt Glimelius, Marianne Jensen Hjermstad, Julia S. Johansen, Elin Kure, et al. 2017. “Health-Related Quality of Life in Patients with Metastatic Colorectal Cancer, Association with Systemic Inflammatory Response and RAS and BRAF Mutation Status.” European Journal of Cancer 81 (August): 26–35. doi:10.1016/j.ejca.2017.04.026.